A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma.
Lewis KD, Robinson WA, Millward MJ, Powell A, Price TJ, Thomson DB, Walpole ET, Haydon AM, Creese BR, Roberts KL, Zalcberg JR, Gonzalez R.
Lewis KD, et al. Among authors: gonzalez r.
Invest New Drugs. 2008 Feb;26(1):89-94. doi: 10.1007/s10637-007-9080-5. Epub 2007 Sep 20.
Invest New Drugs. 2008.
PMID: 17891338
Clinical Trial.